Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Gastric mucosal hypertrophy
ADR ID BADD_A07240
ADR Hierarchy
07      Gastrointestinal disorders
07.11      Gastrointestinal conditions NEC
07.11.03      Gastrointestinal mucosal dystrophies and secretion disorders
07.11.03.006      Gastric mucosal hypertrophy
Description GASTRITIS with HYPERTROPHY of the GASTRIC MUCOSA. It is characterized by giant gastric folds, diminished acid secretion, excessive MUCUS secretion, and HYPOPROTEINEMIA. Symptoms include VOMITING; DIARRHEA; and WEIGHT LOSS. [MeSH]
MedDRA Code 10017807
MeSH ID D005758
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Gastric folds hypertrophy | Gastric mucosal hypertrophy | Gastric mucosal hypertrophy, without mention of hemorrhage | Gastric cell hyperplasia | G cell hyperplasia | Gastric mucosal hypertrophy, without mention of haemorrhage | Menetrier's disease | Antral G-cell hyperplasia | Gastric hyperplasia | Gastric gland hyperplasia | Gastric foveolar hyperplasia | Gastritis, Hypertrophic | Hypertrophic Gastritis | Menetrier Disease | Disease, Menetrier | Menetrier's Disease | Disease, Menetrier's | Menetriers Disease | Giant Hypertrophic Gastritis | Gastritis, Giant Hypertrophic | Hypertrophic Gastritis, Giant | Gastritis, Familial Giant Hypertrophic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine--
BADD_D00725Doxycycline0.000022%
BADD_D01081Hydralazine0.000068%
BADD_D01245Lansoprazole0.000099%
BADD_D01374Meloxicam0.000032%
The 1th Page    1    Total 1 Pages